Abstract 2111: Impact of HER2 Expression on trastuzumab deruxtecan(T-DXd) efficacy

作者
Wanyi Chen,Joshua Z. Drago,Avantika Gupta,Bo Liu,Sarat Chandarlapaty
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 2111-2111
标识
DOI:10.1158/1538-7445.am2024-2111
摘要

Abstract Background: T-DXd is an FDA-approved anti-HER2 Antibody Drug Conjugate (ADC), which has shown clinical efficacy in breast cancers with either overexpression or low-level expression of HER2. The benefit of T-DXd across the spectrum of HER2 expression has called into question the relevance of HER2 expression level as relevant parameter for T-DXd sensitivity. We sought to experimentally address the relevance of HER2 expression level upon the degree of T-DXd response. Methods: A series of isogenic models was generated that expressed different levels of surface HER2 using a doxycycline-inducible promoter. These were analyzed for impact of differential expression level upon T-DXd internalization and drug response. Human breast cancer samples were analyzed for HER2 expression levels and association with clinical response to T-DXd under an IRB approved protocol. Results: Induction of different levels of HER2 at specified doxycycline concentrations was verified in multiple models using immunoblotting and FACS. These different levels appeared to correspond to clinical breast cancer immunohistochemistry (IHC) scoring levels to 0, 1+, 2+, and 3+. The models were analyzed for T-DXd response and showed increasing levels of HER2 led to increase lysosomal uptake of T-DXd (p<0.0001). Moreover, elevation of HER2 levels led to lower concentrations of T-DXd needed to suppress tumor growth. Analyses of the effects of increasing levels of HER2 upon xenograft response to T-DXd are ongoing. Finally, retrospective analyses of a cohort of 50 breast cancer patients treated with T-DXd revealed that higher levels of HER2 corresponded to longer time on treatment (time to progression). Conclusion: We observe a consistent relationship between elevated expression of HER2 and breast cancer response to T-DXd. The findings highlight the relevance of HER2 expression level as a biomarker of T-DXd response and support the potential value of therapeutic strategies that can induce HER2 surface expression levels to enhance response. Citation Format: Wanyi Chen, Joshua Drago, Avantika Gupta, Bo Liu, Sarat Chandarlapaty. Impact of HER2 Expression on trastuzumab deruxtecan(T-DXd) efficacy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 2111.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
wang发布了新的文献求助10
1秒前
1秒前
1秒前
1秒前
斯文败类的应助被Hou采纳,获得10
1秒前
1秒前
cedar完成签到,获得积分10
1秒前
1秒前
2秒前
2秒前
调皮雅柏发布了新的文献求助10
2秒前
万能图书馆的应助被MCQ采纳,获得10
2秒前
2秒前
2秒前
2秒前
汉堡包的应助被小姚霏采纳,获得10
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
落后千雁完成签到,获得积分10
3秒前
3秒前
3秒前
4秒前
dxy发布了新的文献求助10
4秒前
4秒前
4秒前
安静的冬瓜完成签到,获得积分20
4秒前
Code_king发布了新的文献求助10
4秒前
Code_king发布了新的文献求助10
4秒前
Code_king发布了新的文献求助10
4秒前
烟花的应助被www采纳,获得10
5秒前
Zoe发布了新的文献求助10
5秒前
Code_king发布了新的文献求助10
5秒前
Code_king发布了新的文献求助10
5秒前
Code_king发布了新的文献求助10
5秒前
江流儿完成签到,获得积分20
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8176432
求助须知:如何正确求助?哪些是违规求助? 9567768
关于积分的说明 21794704
捐赠科研通 7771112
什么是DOI,文献DOI怎么找? 3431998
关于科研通互助平台的介绍 2556324
邀请新用户注册赠送积分活动 2477671